Publications by authors named "Mohammad Alsharhan"
Article Synopsis
- Lipid injectable emulsions (ILEs) are used in parenteral nutrition to provide energy and essential fatty acids, and their use presents unique challenges compared to oral fats.
- Since 1975, soybean oil has been the primary source for ILEs in the US, but safety concerns and inventory shortages have led to the introduction of new ILE products.
- The paper addresses gaps in best practices for ILEs, aiming to minimize safety errors related to prescribing, compounding, and administration, with Part 1 focusing on adults and Part 2 planned for neonatal and pediatric populations.
The purpose of this review is to evaluate the efficacy and safety of ceftazidime/avibactam and ceftolozane/tazobactam in patients with complicated intra-abdominal infections (cIAI), and review eravacycline and other agents in the pipeline for management of cIAI. The increasing incidence of multidrug resistant strains of bacteria has led to the need for additional antibiotics with activity against these organisms. There are 2 newly approved antibiotics, ceftazidime/avibactam and ceftolazane/tazobactam for treatment of cIAI.
View Article and Find Full Text PDFObjective: To evaluate the appropriate dosing of enoxaparin as a venous thromboembolism (VTE) prophylaxis in hospitalized obese patients.
Data Sources: Literature articles were accessed through MEDLINE (1946 to August week 1, 2013) and EMBASE (1980 to 2013 week 33) searches using the terms enoxaparin, obesity, and thromboprophylaxis.
Study Selection And Data Extraction: All articles that involved human subjects and were published in the English language, evaluating the appropriate dose of enoxaparin for VTE prophylaxis in hospitalized, obese patients were included.